Azacitidine Monotherapy in Patients With Treatment-Naïve Higher-risk Myelodysplastic Syndrome: A Systematic Literature Review and Meta-analysis.

Ken Hasegawa,Andrew H Wei,Guillermo Garcia-Manero,Naval G Daver,Nishanthan Rajakumaraswamy,Shahed Iqbal,Rebecca J Chan, Hao Hu,Preston Tse,Jiajun Yan,Michael J Zoratti,Feng Xie,David A Sallman

Clinical lymphoma, myeloma & leukemia（2023）

引用 2|浏览35

暂无评分

摘要

The effectiveness and efficacy of AZA monotherapy-as measured by CR and median OS-was limited. These findings highlight a significant unmet medical need for effective treatments for patients with higher-risk MDS.

查看译文

关键词

Hypomethylating agents,Mds,Remission,Survival,Treatment outcomes

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要